Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Promising cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New radiation beads aim to shrink untreatable liver tumors
Disease control TerminatedThis early study tested a treatment called Holmium-166 radioembolization for people with liver cancer that cannot be removed by surgery. The treatment uses tiny radioactive beads delivered directly to the tumor. The main goals were to see if it is safe and whether it can shrink t…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Smart insulin pump system tested for type 1 diabetes – study ends early
Disease control TerminatedThis study tested whether an automated insulin delivery system could help adults with type 1 diabetes manage their blood sugar levels. The system combined a continuous glucose monitor, an insulin pump, and a smart algorithm to adjust insulin automatically. Only one person took pa…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Heart rhythm study seeks to predict ablation success
Knowledge-focused TerminatedThis study looked at a common heart rhythm problem called atrial fibrillation (AF). The goal was to find better ways to predict which patients would benefit from a procedure called ablation, which creates scar tissue in the heart to stop abnormal rhythms. Researchers planned to u…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:09 UTC